Du et al. developed a range of cholesterol‐amino‐phosphate (CAP) LNPs to deliver mRNA or saRNA encoding DNA Meiotic Recombinase 1 (Dmc1) to spermatocytes and thus treat male infertility caused by the Dmc1 gene mutation [261]. Here, DMC1 is linked to male infertility.